Investigators focused on a sale of at least $1 million of stock in Cardlytics, a financial firm whose board the senator once sat on. They closed the case this summer without charges.
Investigators focused on a sale of at least $1 million of stock in Cardlytics, a financial firm whose board the senator once sat on. They closed the case this summer without charges.